Koers Rayont, Inc. Other OTC
Aandelen
RAYT
US75508M1009
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 2,97 mln. 2,78 mln. | Omzet 2022 | 2,84 mln. 2,66 mln. | Marktkapitalisatie | 45,69 mln. 42,73 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | - 0 | Nettowinst (verlies) 2022 | - 0 | EV/omzet 2021 | 47,8 x |
Nettoschuld 2021 | 2,4 mln. 2,25 mln. | Nettoschuld 2022 | 7,78 mln. 7,28 mln. | EV/omzet 2022 | 18,8 x |
K/w-verhouding 2021 |
293
x | K/w-verhouding 2022 |
186
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 48,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 31-03-20 | |
Ilenna Copley
COO | Chief Operating Officer | - | 16-05-22 |
Dhurata Toli
BRD | Director/Board Member | 48 | 25-03-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jason Sunstein
BRD | Director/Board Member | 52 | 21-04-22 |
Dhurata Toli
BRD | Director/Board Member | 48 | 25-03-21 |
Chief Executive Officer | 48 | 31-03-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |